Table 3

 Morbidity and treatment of children with atopic and non-atopic wheeze at 10 years of age

Atopic wheezeNon-atopic wheezeOR95% CIp value
*p<0.05 (χ2 test).
Limitation of speech by wheeze in last year16.4% (18/110)10.1% (10/99)1.740.76 to 3.980.184
Sleep disturbance by wheeze more than once per week in last year12.6% (14/111)4.0% (4/99)3.431.09 to 10.790.027*
Wheeze frequency in last year (4 or more episodes in last year)46.4% (51/110)33.3% (32/96)1.730.98 to 3.050.057
Nocturnal cough in last year50.4% (57/113)51.5% (52/101)0.960.56 to 1.640.879
Exercise induced wheeze in last year69.0% (78/113)58.4% (59/101)1.590.91 to 2.780.106
Physician diagnosed asthma ever80.5% (91/113)51.5% (52/101)3.902.12 to 7.16<0.001*
Inhaled steroids ever61.1% (69/113)37.4% (37/99)2.631.51 to 4.58<0.001*
Inhaled bronchodilators ever93.8% (106/113)72.7% (72/99)5.682.35 to 13.74<0.001*
Oral steroids ever41.6% (47/113)14.0% (14/100)4.372.22 to 8.61<0.001*
Specialist referral ever18.6% (21/113)15.0% (15/100)1.290.63 to 2.670.486
Hospitalisation ever25.7% (29/113)16.0% (16/100)1.810.92 to 3.580.085